Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of freeze-dried human diploid cell rabies vaccine using different immunization schedules in participants aged 10 to 60 years
CTR20252277Phase 3Completed
- Sponsor
- Ningbo Rongan Biological Pharmaceutical Co., Ltd.
- Start
- Jul 2025
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of rabies virus inactivated antigen, B in rabies (5 arms), sponsored by Ningbo Rongan Biological Pharmaceutical Co., Ltd. Started Jul 2025; status: completed.
02
Drugs
rabies virus inactivated antigen, B
03
Conditions
rabies
Beyond the preview
Go deeper on CTR20252277.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20252277.